Polypharmacy prevalent in cancer patients with comorbidities
A recent cross-sectional, retrospective study in Saudi Arabia has found a high prevalence of polypharmacy in oncology patients, especially in those with comorbidities such as hypertension, diabetes, asthma, and anxiety.
